• 1. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 2. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 3. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

Introduction to Tert-butyl endo-5-hydroxy-2-azabicyclo[2.2.2]octane-2-carboxylate (CAS No. 1638760-60-7)

Tert-butyl endo-5-hydroxy-2-azabicyclo[2.2.2]octane-2-carboxylate, identified by its CAS number 1638760-60-7, is a structurally complex organic compound that has garnered significant attention in the field of medicinal chemistry and drug discovery. This compound belongs to the class of azabicycloalkanes, which are known for their unique three-membered nitrogen-containing rings embedded within a bicyclic framework. The presence of both hydroxyl and tert-butyl substituents on the molecule imparts distinct chemical properties that make it a promising candidate for further exploration in pharmacological applications.

The molecular structure of tert-butyl endo-5-hydroxy-2-azabicyclo[2.2.2]octane-2-carboxylate features a rigid bicyclic core, which is a common motif in biologically active molecules due to its ability to mimic the conformational constraints found in natural products and peptides. The nitrogen atom in the azabicyclo ring can serve as a hydrogen bond acceptor, enhancing the compound's potential for interactions with biological targets. Additionally, the hydroxyl group at the 5-position and the tert-butyl group at the 2-position contribute to steric and electronic effects that can influence both the reactivity and binding affinity of the molecule.

In recent years, there has been growing interest in azabicycloalkanes as scaffolds for drug development due to their ability to exhibit high binding affinity and selectivity towards various biological targets. For instance, studies have shown that compounds with similar structural motifs can interact with enzymes and receptors involved in inflammatory pathways, making them potential candidates for treating conditions such as arthritis and cancer. The tert-butyl endo-5-hydroxy-2-azabicyclo[2.2.2]octane-2-carboxylate structure, with its unique combination of functional groups, may offer advantages in terms of metabolic stability and oral bioavailability, which are critical factors in drug design.

One of the most compelling aspects of this compound is its potential as a precursor for more complex derivatives through chemical modifications. The presence of both a carboxylate group and a hydroxyl group provides multiple sites for functionalization, allowing chemists to explore a wide range of structural variations. For example, the carboxylate group can be used to link the molecule to other pharmacophores via amide or ester bonds, while the hydroxyl group can be oxidized or reduced to introduce additional functional diversity. Such modifications are essential for optimizing drug-like properties such as solubility, permeability, and pharmacokinetics.

Recent advancements in computational chemistry have also facilitated the design and optimization of molecules like tert-butyl endo-5-hydroxy-2-azabicyclo[2.2.2]octane-2-carboxylate. Molecular modeling techniques, including docking studies and quantum mechanical calculations, have been employed to predict how this compound might interact with biological targets at the atomic level. These studies have provided valuable insights into the binding modes and potential efficacy of the molecule, guiding experimental efforts toward more targeted drug development.

The synthesis of tert-butyl endo-5-hydroxy-2-azabicyclo[2.2.2]octane-2-carboxylate presents both challenges and opportunities for synthetic chemists. The construction of the bicyclic azabicyclo framework requires precise control over reaction conditions to ensure high yield and enantioselectivity, particularly when dealing with stereochemically complex intermediates. However, recent developments in transition metal-catalyzed reactions have made it possible to construct such frameworks in a more efficient and scalable manner. For instance, palladium-catalyzed cyclization reactions have been successfully applied to form the three-membered nitrogen-containing ring under mild conditions.

Furthermore, the introduction of functional groups such as hydroxyl and tert-butyl groups requires careful consideration to avoid unwanted side reactions or degradation pathways. Protecting group strategies have been employed to safeguard these functionalities during synthetic transformations, ensuring their integrity until they can be incorporated into more complex molecules or subjected to final functionalization steps.

The pharmacological potential of tert-butyl endo-5-hydroxy-2-azabicyclo[2.2.2]octane-2-carboxylate has not yet been fully explored, but preliminary studies suggest that it may exhibit interesting biological activities. For example, analogs of azabicycloalkanes have shown promise as kinase inhibitors due to their ability to mimic ATP binding pockets in enzymes such as Janus kinases (JAKs) and tyrosine kinases (Tyrosine Kinase Inhibitors - TKIs). The steric constraints imposed by the bicyclic core can help optimize interactions with these targets by fitting into narrow active sites.

Additionally, the hydroxyl group at position 5 could serve as a site for hydrogen bonding interactions with protein residues or other polar moieties in biological systems. This feature is particularly relevant for designing molecules that interact with transcription factors or signaling proteins involved in cell regulation pathways. The tert-butyl group at position 1 provides steric bulk that could enhance binding affinity by filling gaps or preventing unfavorable conformational changes in protein-ligand complexes.

In conclusion,tert-butyl endo-5-hydroxy-2-azabicyclo[2.2.2]octane-2-carboxylate (CAS No. 1638760- 60 -7) represents an intriguing compound with significant potential in medicinal chemistry. Its unique structural features, combined with recent advances in synthetic methodologies, make it an attractive scaffold for further exploration. As research continues, this molecule may emerge as a key intermediate or lead compound for developing novel therapeutic agents targeting various diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)